Zinc carnosine is a chelated compound that combines the mineral zinc with the amino acid L-carnosine, forming a unique complex most widely recognized under the branded form PepZin GI. Research suggests this compound may help support the integrity of the stomach lining and promote overall digestive comfort, with studies indicating it can adhere to and help protect gastric mucosal tissue. Clinical investigations have explored its potential role in supporting a healthy gut barrier and maintaining balanced conditions in the stomach, including preliminary research examining its effects in individuals dealing with H. pylori concerns. Unlike standard zinc supplements, zinc carnosine appears to release zinc gradually in the stomach, which researchers believe contributes to its localized, gut-supportive properties. It remains one of the more well-studied mineral compounds in the area of gastrointestinal wellness.
Compare this supplementResearch suggests that zinc carnosine may help protect the gut lining from various forms of injury, including drug-in...
View studies →Research on zinc carnosine specifically for digestive health is not represented in the studies provided here. The lin...
View studies →Research suggests that zinc-L-carnosine may offer supportive benefits in the context of Helicobacter pylori eradicati...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 75 mg | Twice daily | Gastric mucosal protection, ulcer support, and general gut health | Most commonly used dose in clinical trials; standard commercial dosing (150 mg/day total) |
| Capsule | 150 mg | Twice daily | H. pylori eradication support as adjunct therapy | Higher dose used in some RCTs investigating H. pylori triple therapy adjunction |
| Capsule | 75 mg | Twice daily | Leaky gut and intestinal permeability support | Based on clinical trials examining intestinal barrier integrity outcomes |
| Capsule | 75–150 mg | Twice daily | NSAID-induced gastric mucosal damage prevention | Dose range observed across multiple clinical studies on gastric protection |